Amendment To Stock Option Agreement Sample Contracts

Amendment to Stock Option Agreements (May 8th, 2018)

This Amendment to Stock Option Agreements (this "Amendment") is entered into between Five Prime Therapeutics, Inc., a Delaware corporation ("FivePrime"), and Marc Belsky, an individual, effective as of April 6, 2018 (the "Amendment Effective Date"). Each capitalized term used but not defined in this Amendment has the meaning assigned to such term in the Stock Option Agreements (as defined below).

Amendment to Stock Option Agreement (_______________) (March 1st, 2018)

This is a [First] Amendment to Stock Option Agreement (the "Amendment"), between Tempur Sealy International, Inc. (the "Company"), and [_______________] (the "Employee" and together with the Company, the "Parties").

Form of Fiserv, Inc. Amendment to Stock Option Agreement (December 1st, 2017)

This Amendment revises your Non-Qualified Stock Option Agreement(s) (Option Agreements) by replacing Section 6(b) in its entirety with the following:

Fiserv, Inc. Amendment to Stock Option Agreement (August 2nd, 2017)

This Amendment revises your Non-Qualified Stock Option Agreement(s) ("Option Agreements") by replacing Sections 6(a) and 6(b) in their entirety with the following:

Advanced Drainage Systems, Inc. – Amendment to Stock Option Agreements (May 30th, 2017)

This AMENDMENT TO STOCK OPTION AGREEMENTS (this "Amendment") is entered into effective as of April 1, 2017 by and between Advanced Drainage Systems, Inc., a Delaware corporation (the "Company"), and the undersigned (the "Optionee").

Foreclosure Solutions – Amendment to Stock Option Agreement (May 9th, 2017)

This Amendment to Stock Option Agreement (this "Amendment") is entered into by and between MICHAEL MONA, JR., an individual ("Executive"), and CV SCIENCES, INC., a Delaware corporation (the "Company") as of March 16, 2017 (the "Effective Date"), with reference to the following facts:

Foreclosure Solutions – Amendment to Stock Option Agreement (May 9th, 2017)

This Amendment to Stock Option Agreement (this "Amendment") is entered into by and between MICHAEL MONA, III, an individual ("Executive"), and CV SCIENCES, INC., a Delaware corporation (the "Company") as of March 16, 2017 (the "Effective Date"), with reference to the following facts:

Foreclosure Solutions – Amendment to Stock Option Agreement (May 9th, 2017)

This Amendment to Stock Option Agreement (this "Amendment") is entered into by and between JOSEPH DOWLING, an individual ("Executive"), and CV SCIENCES, INC., a Delaware corporation (the "Company") as of March 16, 2017 (the "Effective Date"), with reference to the following facts:

Fortress Intl Group Inc – Amendment to Stock Option Agreement (April 11th, 2017)

This Amendment to Stock Option Agreement (this "Amendment") is made as of April 10, 2017, between TSS, Inc. (the "Company") and Anthony Angelini (the "Executive").

Fortress Intl Group Inc – Amendment to Stock Option Agreement (April 11th, 2017)

This Amendment to Stock Option Agreement (this "Amendment") is made as of April 10, 2017, between TSS, Inc. (the "Company") and Anthony Angelini (the "Executive").

DJO Finance LLC – Retirement Agreement and Amendment to Stock Option Agreements (November 15th, 2016)

This Retirement Agreement and Amendment to Stock Option Agreements (the Agreement) is entered into as of November 14, 2016, by and between Michael Mogul (Executive) and DJO Global, Inc., a Delaware corporation (the Company).

Amendment to Stock Option Agreement (November 14th, 2016)

This Amendment to Stock Option Agreement (this "Amendment") is made effective as of August 29, 2016, by and between _____________________ (the "Participant") and COPsync, Inc., a Delaware corporation (the "Company").

Fnb United Corp – AMENDMENT TO STOCK OPTION AGREEMENTS [B. DeSimone] (October 4th, 2016)

This Amendment to Stock Option Agreements (this "Amendment") is made and entered into as of October 3, 2016, by and between CommunityOne Bancorp, a North Carolina corporation (the "Company) and Beth S. DeSimone (the "Participant").

Fnb United Corp – AMENDMENT TO STOCK OPTION AGREEMENTS [D. Nielsen] (October 4th, 2016)

This Amendment to Stock Option Agreements (this "Amendment") is made and entered into as of October 3, 2016, by and between CommunityOne Bancorp, a North Carolina corporation (the "Company) and David L. Nielsen (the "Participant").

Fnb United Corp – AMENDMENT TO STOCK OPTION AGREEMENTS [A. McBryde] (October 4th, 2016)

This Amendment to Stock Option Agreements (this "Amendment") is made and entered into as of October 3, 2016, by and between CommunityOne Bancorp, a North Carolina corporation (the "Company) and Angus M. McBryde, III (the "Participant").

Vision Global Solutions – First Amendment to Stock Option Agreement (March 11th, 2016)

This FIRST AMENDMENT TO STOCK OPTION AGREEMENT (this "Amendment") is entered into on and as of March 7, 2016 (the "Amendment Date") between Eco-Stim Energy Solutions, Inc., a Nevada corporation (the "Company"), and Jogeir Romestrand ("Recipient"). Recipient and the Company are collectively referred to in this Amendment as the "Parties." Capitalized terms used but not defined herein shall have the meanings set forth in the Eco-Stim Energy Solutions, Inc. 2013 Stock Incentive Plan (the "Plan").

Amendment to Stock Option Agreements (September 22nd, 2015)

This Amendment to Stock Option Agreements is entered into as of June 29, 2015 (the Effective Date), between The Kroger Co., an Ohio corporation (Kroger), and Michael Ellis (you).

Carrollton Bancorp/Md – BAY BANCORP, INC. FIRST AMENDMENT TO STOCK OPTION AGREEMENT Granted Under the Carrollton Bancorp 2007 Equity Plan (December 5th, 2014)

This First Amendment to Stock Option Agreement (this "Amendment") is made and entered into as of ___________, ___ (the "Effective Date") by and between Bay Bancorp, Inc., f/k/a Carrollton Bancorp, a Maryland corporation (the "Company"), and Kevin B. Cashen ("Participant").

Cerulean Pharma Inc. – Amendment to Stock Option Agreement and Termination of Contingent Consideration Award (November 13th, 2014)

THIS AMENDMENT TO STOCK OPTION AGREEMENT AND TERMINATION OF CONTINGENT CONSIDERATION AWARD (this Amendment), dated as of September 16, 2014, is entered into by and between Cerulean Pharma Inc., a Delaware corporation (the Company), and Alan Crane (the Participant).

Kadant Inc – Kadant Inc. Notice of Amendment to Stock Option Agreements (November 5th, 2014)
Amendment to Stock Option Agreements (October 20th, 2014)

This document constitutes an amendment to all outstanding Walgreen Co. stock option agreements (the "Agreements") under the Walgreen Co. Executive Stock Option Plan (the "Stock Option Plan") and the 2013 Omnibus Incentive Plan (the "Omnibus Plan") but only to the extent of the following with respect to each of the Agreements:

Fibrogen, Inc. Amendment to Stock Option Agreement Granted Under 1999 Stock Plan (October 1st, 2014)

Pursuant to your Election to Participate in FibroGens Amendment and Exchange Offer ending on June 24, 2010 (your Election), this Amendment (the Amendment) is entered into and made effective on June 24, 2010 (the Amendment Effective Date) by and between you, [ ] (Optionee) and FibroGen, Inc. and its subsidiaries (Company). This Amendment amends the Stock Option Agreement that governs the option with Option Grant Number [ ] (now referred to as MA[ ]) granted on [ ] for [ ] shares of FibroGen Common Stock, for which you have agreed to amend pursuant to your executed Election (the Option Agreement). Optionee and Company shall be referred to individually herein as a Party, and collectively as, the Parties. The Option Agreement, together with its corresponding Option Grant Notice and this Amendment are collectively referred to as the Agreement.

Fibrogen, Inc. Amendment to Stock Option Agreement Granted Under 2005 Stock Plan (October 1st, 2014)

Pursuant to your Election to Participate in FibroGens Amendment and Exchange Offer ending on June 24, 2010 (your Election), this AMENDMENT (the Amendment) is entered into and made effective on June 24, 2010 (the Amendment Effective Date) by and between you, [ ] (Optionee) and FibroGen, Inc. and its subsidiaries (Company). This Amendment amends the Stock Option Agreement that governs the option with Option Grant Number [ ] (now referred to as MA[ ]) granted on [ ] for [ ] shares of FibroGen Common Stock, for which you have agreed to amend pursuant to your executed Election (the Option Agreement). Optionee and Company shall be referred to individually herein as a Party, and collectively as, the Parties. The Option Agreement, together with its corresponding Option Grant Notice and this Amendment are collectively referred to as the Agreement.

Fibrogen, Inc. Amendment to Stock Option Agreements (October 1st, 2014)

THIS AMENDMENT (the Amendment) is entered into and made effective on July 1, 2013 (the Amendment Effective Date) by and between you, (Optionee) and FibroGen, Inc. (Company). This Amendment amends your Stock Option Agreements that govern the option grants listed on Exhibit A hereto (the Option Agreements). Optionee and Company shall be referred to individually herein as a Party, and collectively as, the Parties. The Option Agreements, together with its corresponding Option Grant Notice, this Amendment, and any previous Amendments thereof, are collectively referred to as the Agreement.

Upland Software, Inc. 2010 Stock Plan Amendment to Stock Option Agreement (September 4th, 2014)

This Amendment to Stock Option Agreement (this Amendment) is made effective as of , 2014 (the Amendment Date) by and between Upland Software, Inc., a Delaware corporation (the Company), and (the Participant). Capitalized terms used but not defined herein shall have the respective meanings assigned to them in the Upland Software, Inc. 2010 Stock Plan, as amended (the Plan) or the Stock Option Agreement previously entered into between the Company and the Participant with respect to the Option (as defined below) (the Stock Option Agreement).

Of Amendment to Stock Option Agreement (August 7th, 2014)

Reference is made to the Stock Option Agreement (the "Option Agreement") dated [Date] between you and Covisint Corporation (the "Corporation") pursuant to which the Company granted to you a stock option to purchase [#shares] shares of the Corporation's common stock ("Shares") at $[price] per share, upon the terms and conditions contained therein and in the Covisint Corporation 2009 Long Term Incentive Plan (the "Plan"), as amended by that certain amendment dated May 8, 2014 pursuant to which the Corporation added a "tandem" Stock Appreciation Right (the "Tandem SAR Amendment"). Pursuant to this Notice of Rescission, the Corporation hereby rescinds the Tandem SAR Amendment in its entirety, effective as of the initial effective date thereof, such that the Tandem SAR Amendment shall have no force or effect whatsoever and shall create no rights or obligations whatsoever of one party against the other and the Option Agreement shall remain in full force and effect as if such Tandem SAR Amen

Amendment to Stock Option Agreements (July 16th, 2014)

This Amendment to Stock Option Agreements, hereinafter referred to as the "Amendment" or the "Agreement," is made on this 14th day of March, 2014, between ConAgra Foods, Inc., a Delaware corporation ("ConAgra Foods"), and Brian Keck (the "Retiree"). ConAgra Foods and Retiree agree as follows:

Notice of Rescission of Amendment to Stock Option Agreement (June 23rd, 2014)

Reference is made to the Stock Option Agreement (the "Option Agreement") dated [Date] between you and Covisint Corporation (the "Corporation") pursuant to which the Company granted to you a stock option to purchase [#shares] shares of the Corporation's common stock ("Shares") at $[price] per share, upon the terms and conditions contained therein and in the Covisint Corporation 2009 Long Term Incentive Plan (the "Plan"), as amended by that certain amendment dated May 8, 2014 pursuant to which the Corporation added a "tandem" Stock Appreciation Right (the "Tandem SAR Amendment"). Pursuant to this Notice of Rescission, the Corporation hereby rescinds the Tandem SAR Amendment in its entirety, effective as of the initial effective date thereof, such that the Tandem SAR Amendment shall have no force or effect whatsoever and shall create no rights or obligations whatsoever of one party against the other and the Option Agreement shall remain in full force and effect as if such Tandem SAR Amen

Fibrogen, Inc. Amendment to Stock Option Agreement Granted Under 2005 Stock Plan (June 11th, 2014)

Pursuant to your Election to Participate in FibroGens Amendment and Exchange Offer ending on June 24, 2010 (your Election), this AMENDMENT (the Amendment) is entered into and made effective on June 24, 2010 (the Amendment Effective Date) by and between you, [ ] (Optionee) and FibroGen, Inc. and its subsidiaries (Company). This Amendment amends the Stock Option Agreement that governs the option with Option Grant Number [ ] (now referred to as MA[ ]) granted on [ ] for [ ] shares of FibroGen Common Stock, for which you have agreed to amend pursuant to your executed Election (the Option Agreement). Optionee and Company shall be referred to individually herein as a Party, and collectively as, the Parties. The Option Agreement, together with its corresponding Option Grant Notice and this Amendment are collectively referred to as the Agreement.

Fibrogen, Inc. Amendment to Stock Option Agreements (June 11th, 2014)

THIS AMENDMENT (the Amendment) is entered into and made effective on July 1, 2013 (the Amendment Effective Date) by and between you, (Optionee) and FibroGen, Inc. (Company). This Amendment amends your Stock Option Agreements that govern the option grants listed on Exhibit A hereto (the Option Agreements). Optionee and Company shall be referred to individually herein as a Party, and collectively as, the Parties. The Option Agreements, together with its corresponding Option Grant Notice, this Amendment, and any previous Amendments thereof, are collectively referred to as the Agreement.

Fibrogen, Inc. Amendment to Stock Option Agreement Granted Under 1999 Stock Plan (June 11th, 2014)

Pursuant to your Election to Participate in FibroGens Amendment and Exchange Offer ending on June 24, 2010 (your Election), this Amendment (the Amendment) is entered into and made effective on June 24, 2010 (the Amendment Effective Date) by and between you, [ ] (Optionee) and FibroGen, Inc. and its subsidiaries (Company). This Amendment amends the Stock Option Agreement that governs the option with Option Grant Number [ ] (now referred to as MA[ ]) granted on [ ] for [ ] shares of FibroGen Common Stock, for which you have agreed to amend pursuant to your executed Election (the Option Agreement). Optionee and Company shall be referred to individually herein as a Party, and collectively as, the Parties. The Option Agreement, together with its corresponding Option Grant Notice and this Amendment are collectively referred to as the Agreement.

Amendment to Stock Option Agreement (May 13th, 2014)

Reference is made to the Stock Option Agreement (the "Agreement") dated [Date] between you and Covisint Corporation (the "Corporation") pursuant to which the Company granted to you the Option to purchase [#shares] Shares at $[price] per share, upon the terms and conditions contained therein and in the 2009 Long Term Incentive Plan (the "Plan"). Pursuant to the Plan and with the approval of the Corporation's Board of Directors in accordance with the Plan, the Corporation amends your Agreement, as set forth herein, to add a new "tandem" Stock Appreciation Right (the "SAR"). The SAR is applicable only to the portion of your Option that is exercisable in 2014 (the "2014 Portion"). The SAR becomes exercisable on June 24, 2014, and it will expire on the earliest of the date of Compuware Corporation's distribution of the common stock of the Corporation to its shareholders, the exercise of the related Option, or December 26, 2014.

Amendment to Stock Option Agreement (May 12th, 2014)

Reference is made to the Stock Option Agreement (the "Agreement") dated [Date] between you and Covisint Corporation (the "Corporation") pursuant to which the Company granted to you the Option to purchase [#shares] Shares at $[price] per share, upon the terms and conditions contained therein and in the 2009 Long Term Incentive Plan (the "Plan"). Pursuant to the Plan and with the approval of the Corporation's Board of Directors in accordance with the Plan, the Corporation amends your Agreement, as set forth herein, to add a new "tandem" Stock Appreciation Right (the "SAR"). The SAR is applicable only to the portion of your Option that is exercisable in 2014 (the "2014 Portion"). The SAR becomes exercisable on June 24, 2014, and it will expire on the earliest of the date of Compuware Corporation's distribution of the common stock of the Corporation to its shareholders, the exercise of the related Option, or December 31, 2014.

Bind Therapeutics, Inc. 2006 Stock Incentive Plan Omnibus Amendment to Stock Option Agreements (January 17th, 2014)

This OMNIBUS AMENDMENT TO STOCK OPTION AGREEMENTS (the Amendment), is made effective as of January 13, 2014, by and between BIND Therapeutics, Inc., a Delaware corporation (the Company), and Greg Berk (the Participant). Except as set forth in this Amendment, capitalized terms used but not defined herein shall have the meanings ascribed to them in the Companys 2006 Stock Incentive Plan (as amended, the Plan).

William Lyon Homes 2012 Equity Incentive Plan Amendment to Stock Option Agreement (December 27th, 2013)

This Amendment to the Stock Option Agreement (the Amendment) is entered into by and between William Lyon Homes (the Company), and [ ] (the Optionee) on December 3, 2013 (the Effective Date) pursuant to the resolutions adopted by the Compensation Committee of the Board of Directors of the Company (the Board) on November 5, 2013 and amends the Stock Option Agreement under the Companys 2012 Equity Incentive Plan between the parties hereto (the Original Agreement). Capitalized terms used here and not defined herein shall have the meaning given in the Original Agreement.